Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junyeop Lee

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
Antimicrobial Agents and Chemotherapy|January 30, 2016
Incidence and Risk Factors of Ocular Infection Caused by Staphylococcus aureus BacteremiaJiwon Jung, Junyeop Lee, Shi Nae Yu, et al.
Cancer Cell|June 30, 2026
Vascular RhoJ Is an Effective and Selective Target for Tumor Angiogenesis and Vascular DisruptionChan Kim, Hanseul Yang, Yoko Fukushima, et al.
Cancer Cell|January 18, 2014
Vascular RhoJ is an effective and selective target for tumor angiogenesis and vascular disruptionChan Kim, Hanseul Yang, Yoko Fukushima, et al.
Circulation Research|February 21, 2020
Dll4 Suppresses Transcytosis for Arterial Blood-Retinal Barrier HomeostasisJee Myung Yang, Chan Soon Park, Soo Hyun Kim, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 21, 2014
Endothelial deletion of phospholipase D2 reduces hypoxic response and pathological angiogenesisJaewang Ghim, Jin-Sook Moon, Chang Sup Lee, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
Antimicrobial Agents and Chemotherapy|January 30, 2016
Incidence and Risk Factors of Ocular Infection Caused by Staphylococcus aureus BacteremiaJiwon Jung, Junyeop Lee, Shi Nae Yu, et al.
Cancer Cell|June 30, 2026
Vascular RhoJ Is an Effective and Selective Target for Tumor Angiogenesis and Vascular DisruptionChan Kim, Hanseul Yang, Yoko Fukushima, et al.
Cancer Cell|January 18, 2014
Vascular RhoJ is an effective and selective target for tumor angiogenesis and vascular disruptionChan Kim, Hanseul Yang, Yoko Fukushima, et al.
Circulation Research|February 21, 2020
Dll4 Suppresses Transcytosis for Arterial Blood-Retinal Barrier HomeostasisJee Myung Yang, Chan Soon Park, Soo Hyun Kim, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 21, 2014
Endothelial deletion of phospholipase D2 reduces hypoxic response and pathological angiogenesisJaewang Ghim, Jin-Sook Moon, Chang Sup Lee, et al.
Pageof 9